Showing results (241-250 of 319) with videos related to

Sort By:
Pageof 32
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
Internal and Emergency Medicine|November 20, 2023
Physical activity in liver transplant recipients: a large multicenter studyStefano Gitto, Lucia Golfieri, Filippo Gabrielli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2020
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLDStefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2024
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinomaFrancesco Tovoli, Dante Pio Pallotta, Caterina Vivaldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisLars Bossen, Paola Rebora, Francesca Bernuzzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2025
Neoadjuvant Under-Dilated TIPS: Expanding Surgeries for Extrahepatic Malignancies in Patients With Cirrhosis and CSPHDario Saltini, Davide Roccarina, Marco Senzolo, et al.
Minerva Gastroenterology|May 10, 2023
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter studyStefano Gitto, Lucia Golfieri, Francesco Sofi, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2026
Vessels Encapsulating Tumor Clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab-bevacizumabAlexandre Sayadi, Claudia Campani, Astrid Laurent-Bellue, et al.
Journal of Hepatology|January 23, 2021
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Elena Sacco, et al.
Pageof 32